Fungal infections are a major contributor to infectious disease-related deaths across the
globe. Candida species are among the most common causes of invasive mycotic disease …

Candida auris, a recently recognized, often multidrug-resistant yeast, has become a
significant fungal pathogen due to its ability to cause invasive infections and outbreaks in …

Antifungal drug resistance represents a serious global health threat, necessitating new
treatment strategies. Here we investigated collateral sensitivity (CS), in which resistance to …

Highlights•C. auris exhibits resistance to multiple antifungal agents and represents a public
health threat.•The molecular mechanisms of antifungal resistance observed in C. auris vary …

Candida auris is an emerging multi-drug resistant yeast, that causes major issues regarding
patient treatment and surface disinfection in hospitals. Indeed, an important proportion of C …

Human fungal pathogens are attributable to a significant economic burden and mortality
worldwide. Antifungal treatments, although limited in number, play a pivotal role in …

Candida auris is globally recognized as an opportunistic fungal pathogen of high concern,
due to its extensive multidrug resistance (MDR). Still, molecular mechanisms of MDR are …

Candida auris is an emerging species of yeast characterized by colonization of skin,
persistence in the healthcare environment, and antifungal resistance. C. auris was first …

Over a decade ago, a multidrug-resistant nosocomial fungus Candida auris emerged
worldwide and has since become a significant challenge for clinicians and microbiologists …

Candida auris has emerged as a multidrug-resistant pathogen of great clinical concern.
Approximately 90% of clinical C. auris isolates are resistant to fluconazole, the most …